ZOSANO PHARMA CORP's ticker is ZSAN and the CUSIP is 98979H202. A total of 1 filers reported holding ZOSANO PHARMA CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $32,000 | -8.6% | 144,667 | +93.1% | 0.00% | – |
| Q4 2021 | $35,000 | +400.0% | 74,912 | +673.7% | 0.00% | – |
| Q3 2021 | $7,000 | -30.0% | 9,682 | -6.7% | 0.00% | – |
| Q2 2021 | $10,000 | -56.5% | 10,377 | -43.5% | 0.00% | – |
| Q1 2021 | $23,000 | +64.3% | 18,352 | -34.1% | 0.00% | – |
| Q4 2020 | $14,000 | -93.5% | 27,859 | -78.9% | 0.00% | – |
| Q3 2020 | $214,000 | +275.4% | 131,973 | +99.4% | 0.00% | – |
| Q2 2020 | $57,000 | +1.8% | 66,172 | -33.8% | 0.00% | – |
| Q1 2020 | $56,000 | -46.7% | 99,932 | +45.8% | 0.00% | – |
| Q4 2019 | $105,000 | +90.9% | 68,557 | +93.1% | 0.00% | – |
| Q3 2019 | $55,000 | -68.9% | 35,500 | -34.4% | 0.00% | – |
| Q2 2019 | $177,000 | +35.1% | 54,094 | +96.7% | 0.00% | – |
| Q1 2019 | $131,000 | +718.8% | 27,500 | +266.7% | 0.00% | – |
| Q4 2018 | $16,000 | -5.9% | 7,500 | +74.8% | 0.00% | – |
| Q3 2018 | $17,000 | +1600.0% | 4,290 | +1602.4% | 0.00% | – |
| Q1 2018 | $1,000 | – | 252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 526,741 | $278,000 | 0.47% |
| Aisling Capital Management LP | 2,718,226 | $1,433,000 | 0.25% |
| Sio Capital Management, LLC | 427,542 | $225,000 | 0.05% |
| Virtu Financial LLC | 198,673 | $105,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 121,978 | $64,000 | 0.01% |
| Wealthcare Advisory Partners LLC | 68,754 | $36,000 | 0.00% |
| Highlander Capital Management, LLC | 10,000 | $5,000 | 0.00% |
| WINTON GROUP Ltd | 66,873 | $35,000 | 0.00% |
| Compagnie Lombard Odier SCmA | 60,000 | $32,000 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $527,000 | 0.00% |